Evidence mapPaperPMID 42440674Full record

ArticleRSC advances2026

Pharmacophore-based virtual screening, molecular docking, MD simulation, MM-GBSA energy calculation and DFT analysis for the

Sundarrajan T, Neerugatti Dora Babu, Anitha K N, Sadik Shaik, Shankar M, Shankar Thapa

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sundarrajan TDepartment of Pharmaceutical Chemistry, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology Kattankulathur Chengalpattu 603 203 Tamil Nadu India sundarrt@srmist.edu.in.ORCID https://orcid.org/0000-0002-6482-8101
Neerugatti Dora BabuDepartment of Pharmacognosy, College of Pharmacy, Al-Mansoor University Baghdad Iraq neeruguttu.d.babu@muc.edu.iq.ORCID https://orcid.org/0000-0002-4608-6538
Anitha K NDepartment of Pharmacology, Government College of Pharmacy Bengaluru-560027 Karnataka India knanita@gmail.com.ORCID https://orcid.org/0000-0003-0602-3273
Sadik ShaikDepartment of Pharmacology, Anuradha College of Pharmacy Bengaluru-560091 India shaikpharmacy@gmail.com.ORCID https://orcid.org/0000-0003-0176-3504
Shankar MDepartment of Pharmaceutical Chemistry, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University B.G Nagara-571448 India shankarm@accp.co.in shankarmanichellappa@gmail.com.ORCID https://orcid.org/0000-0002-2021-3981
Shankar ThapaDepartment of Pharmaceutical Chemistry, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University B.G Nagara-571448 India shankarm@accp.co.in shankarmanichellappa@gmail.com.ORCID https://orcid.org/0000-0003-1801-5668

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid emergence of antimicrobial resistance demands the discovery of new antibacterial targets and inhibitors.

Identifiers

PMID42440674
PMCPMC13334278

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.